Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
1.320
+0.080 (6.45%)
At close: Apr 2, 2025, 4:00 PM
1.240
-0.080 (-6.06%)
After-hours: Apr 2, 2025, 7:53 PM EDT

Mural Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-128.51-207.45-189.81-175.43
Depreciation & Amortization
3.512.571.541.47
Loss (Gain) From Sale of Assets
0.1---
Asset Writedown & Restructuring Costs
0.92---
Loss (Gain) From Sale of Investments
-3.6---
Stock-Based Compensation
5.0824.1111.9311.5
Change in Accounts Payable
-2.43-18.258.395.52
Change in Other Net Operating Assets
-3.624.77-0.640.27
Operating Cash Flow
-128.55-194.25-168.59-156.67
Capital Expenditures
-0.09-3.45-5.51-4.39
Sale of Property, Plant & Equipment
0.07---
Investment in Securities
-25.31---
Investing Cash Flow
-25.33-3.45-5.51-4.39
Issuance of Common Stock
0.2---
Other Financing Activities
-468.81174.1161.05
Financing Cash Flow
0.2468.81174.1161.05
Net Cash Flow
-153.68271.11--
Free Cash Flow
-128.64-197.7-174.1-161.05
Free Cash Flow Per Share
-7.59-11.85-10.43-
Levered Free Cash Flow
-82.24-113.89-99.81-
Unlevered Free Cash Flow
-82.24-113.89-99.81-
Change in Net Working Capital
4.3314.47-7.81-
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q